(Q24796747)

2 July 2017

1 reference

17 November 2019

Deficits in plasma oestradiol measurement in studies and management of breast cancer (English)

1 reference

2 July 2017

1 reference

17 November 2019

1 reference

17 November 2019

1

Mitch Dowsett

1 reference

2 July 2017

Elizabeth Folkerd

2

1 reference

2 July 2017

language of work or name

English

0 references

publication date

28 October 2004

7 references

2 July 2017

13 March 2019

3 April 2019

18 June 2019

17 June 2019

13 November 2019

17 November 2019

Breast Cancer Research

7 references

2 July 2017

13 March 2019

3 April 2019

18 June 2019

17 June 2019

13 November 2019

17 November 2019

7

1 reference

2 July 2017

issue

1

1 reference

2 July 2017

page(s)

1-4

1 reference

Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma

2 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064106

Aromatase inhibitors in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064106

Drug and hormone interactions of aromatase inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064106

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

28 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR960

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR960

Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064106

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15642174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR960

1 reference

Dimensions Publication ID

2 July 2017

1009804824

0 references

PMC publication ID

1064106

0 references

1 reference